Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients
Open Access
- 19 January 2022
- journal article
- research article
- Published by SAGE Publications in Biomarker Insights
- Vol. 17
Abstract
Background: Methylation at 5 CpG sites was previously shown to classify chronic lymphocytic leukemia (CLL) into 3 prognostic subgroups. Here, we aimed to validate the marker set in an additional cohort and to evaluate its clinical utility for CLL patient stratification. Methods: We evaluated this epigenetic marker set in 79 German patients using bisulfite treatment followed by pyrosequencing and classification using a support vector machine-learning tool. Results: The n-CLL, i-CLL, and m-CLL classification was detected in 28 (35%), 10 (13%), and 41 (51%) patients, respectively. Epigenetic grouping was associated with IGHV mutational status ( P = 2 × 10 −12 ), isolated del13q ( P = 9 × 10 −6 ), del17p ( P = .015), complex karyotype ( P = .005), VH-usage, and clinical outcome as time to first treatment ( P = 1.4 × 10 −12 ) and overall survival ( P = .003). Multivariate Cox regression analysis identified n-CLL as a factor for earlier treatment hazard ratio (HR), 6.3 (95% confidence interval [CI] 2.4-16.4; P = .0002) compared to IGHV mutational status (HR 4.6, 95% CI 1.9-11.3, P = .0008). In addition, when comparing the prognostic value of the epigenetic classification system with the IGHV classification, epigenetic grouping performed better compared to IGHV mutational status using Kaplan-Meier estimation and allowed the identification of a third, intermediate (i-CLL) group. Thus, our study confirmed the prognostic value of the epigenetic marker set for patient stratification in routine clinical diagnostics.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 18 references indexed in Scilit:
- Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendationsLeukemia, 2017
- An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient dataThe Lancet Oncology, 2016
- Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2Epigenetics, 2016
- DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaNature Genetics, 2016
- A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impactLeukemia, 2014
- Inherited Susceptibility to CLL2013
- Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemiaNature Genetics, 2012
- Methylation-sensitive high-resolution meltingNature Protocols, 2008
- The clinical and epidemiological burden of chronic lymphocytic leukaemiaEuropean Journal of Cancer Care, 2004
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981